MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$26,661K
Free Cash flow
-$14,577K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable securit...
Accrued expenses
Stock-based compensation expense
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Accretion of discounts on market...
Non-cash lease income
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-18,086
41,667
-21,059
-38,646
Stock-based compensation expense
1,543
-3,167
1,383
3,176
Depreciation
24
-66
31
69
Accretion of discounts on marketable securities
382
-1,873
694
1,564
Non-cash lease income
3
-5
3
4
Gain on termination of lease, net
0
24
-
-
Loss on sales and disposals of fixed assets, net
-25
37
1
-38
Other, net
0
-16
-1
16
Prepaid expenses and other assets
-253
2,952
162
-3,167
Operating lease right-of-use assets and liabilities
0
-
-
-
Accounts payable
389
1,656
801
-3,981
Accrued expenses
1,660
-2,262
-117
1,193
Net cash used in operating activities
-14,577
36,709
-19,820
-36,568
Purchases of property and equipment
0
-14
-1
15
Proceeds from sale of property and equipment
-31
-
1
30
Purchases of marketable securities
26,728
-56,486
20,473
46,689
Maturities of marketable securities
14,501
-87,373
32,499
86,374
Net cash provided by investing activities
-12,227
-30,904
12,028
39,700
Proceeds from the exercise of stock options
-
0
-
-
Proceeds from the exercise of stock options and common stock issued under the 2020 plan
30
-
0
113
Net cash provided by financing activities
143
-113
0
113
Impact of exchange rates on cash and cash equivalents
0
-6
2
6
Net (decrease) increase in cash and cash equivalents
-26,661
5,686
-7,790
3,251
Cash and cash equivalents - beginning of period
36,337
36,337
40,876
-
Cash and cash equivalents - end of period
12,469
39,130
36,337
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
something is missing
$113K
Proceeds from the
exercise of stock options...
$30K
(-73.45%↓ Y/Y)
Net cash provided by
financing activities
$143K
(26.55%↑ Y/Y)
Net (decrease)
increase in cash and cash...
-$26,661K
(-920.09%↓ Y/Y)
Canceled cashflow
$143K
Accrued expenses
$1,660K
(39.15%↑ Y/Y)
Stock-based compensation
expense
$1,543K
(-51.42%↓ Y/Y)
Accounts payable
$389K
(109.77%↑ Y/Y)
Prepaid expenses and
other assets
-$253K
(92.01%↑ Y/Y)
Loss on sales and
disposals of fixed assets,...
-$25K
(34.21%↑ Y/Y)
Depreciation
$24K
(-65.22%↓ Y/Y)
Maturities of marketable
securities
$14,501K
(-83.21%↓ Y/Y)
Net cash used in
operating activities
-$14,577K
(60.14%↑ Y/Y)
Net cash provided by
investing activities
-$12,227K
(-130.80%↓ Y/Y)
Canceled cashflow
$3,894K
Canceled cashflow
$14,501K
Net loss
-$18,086K
(53.20%↑ Y/Y)
Purchases of marketable
securities
$26,728K
(-42.75%↓ Y/Y)
Accretion of discounts on
marketable securities
$382K
(-75.58%↓ Y/Y)
Non-cash lease income
$3K
(-25.00%↓ Y/Y)
Buy us a coffee
PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. (PMVP)